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April 13, 2010:1643–7hose with unsuccessful PCI or suboptimal post-PCI epicardial
ow (Thrombolysis In Myocardial Infarction flow grade 3).
Why the apparent discord? Our larger cohort provided more
nd-point events (144 vs. 27 deaths at 30 days). Moreover,
ejersten et al. (1) found a relationship between ST-segment
ecovery and mortality when both reperfusion strategies were
ggregated; hence, we believe that this is the key finding to
mphasize rather than diverse associations within each strategy
the interaction between ST-segment resolution, death, and treat-
ent assignment in their study was not significant [p  0.40]).
A substantial portion of ST-segment elevation myocardial
nfarction patients have suboptimal outcomes despite primary PCI.
n our study using a simple worst-lead residual ST-segment
levation method, we found that 32% of such patients had excess
ortality and morbidity.
The universally available, inexpensive, noninvasive ST-segment
ecovery metric provides a powerful tool for early prognostication.
his remains true regardless of the reperfusion strategy and can be
eadily incorporated into routine clinical practice and guidelines.
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eply
r. Buller and colleagues in a comment to our previously pub-
ished paper (1) call for some more reflection based on their
revious work in this field. ST-segment resolution turned out to be
uch a powerful prognosticater after fibrinolysis and became so
ecognized that it constitutes a paradigm. ST-segment resolutionas even been used as surrogate end point in several subsequent
rials. Our substudy from the DANAMI 2 trial (1) provided a
nique opportunity to explore the prognostic value of ST-segment
ecovery within the context of a randomized clinical trial compar-
ng fibrinolysis and primary percutaneous coronary intervention
PCI). Admittedly to our surprise, ST-segment recovery did not
redict 30-day mortality in the subset of 602 patients assigned to
rimary PCI. Dr. Buller and colleagues point to some of the
mportant differences between our study and their larger cohort
rom the APEX-AMI (Assessment of PEXilizumab in Acute
yocardial Infarction) trial (2) in which all patients were treated
ith primary PCI. It is possible that the earlier measure of
T-segment recovery after primary PCI (mean 32 min) provides a
tronger signal. We have subsequently calculated the earliest
vailable electrocardiogram in DANAMI-2 to be performed at
ean of 101 min post-PCI. Also, as pointed out in their larger
tudy, more end points occurred but still did not include a
omparably sized group treated with fibrinolysis for comparison.
The apparent discord with previous reports could also be
ublication bias. We are confident that there will be more
ublications in this field in the near future with further insight into
he background of our findings. Until then, ST-segment recovery
rovides a powerful tool for early recognition of failed reperfusion
fter fibrinolysis and thus prognostication. Furthermore, in this
ontext, the lack of ST-segment recovery has real clinical relevance
ecause rescue angioplasty can be offered, whereas the lack of
T-segment recovery after optimal primary PCI in the otherwise
ptimally medically managed patient is of little clinical conse-
uence.
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